Researchers create miniature livers to support NASH R&D
Researchers show miniature livers can develop steatohepatitis and fibrosis, pointing to potential for personalized hepatic drug discovery and toxicity platforms.
Archives for August 20, 2019
Schrödinger extends drug discovery partnership with Morphic
Schrödinger secures further funding, extends collaboration with Morphic Therapeutic on computational discovery platform for oral integrin drugs for the second time.
PRA establishes greater global footprint through data solutions agreement
PRA Health Sciences’ data solutions division, Symphony Health, expands its global data services, as it enters a strategic partnership with Close-Up.
Oral arthritis treatment from AbbVie to enter the market
Rinvoq from AbbVie to be available in the US in late August 2019, after receiving FDA approval for the treatment of adults with active rheumatoid arthritis.
First bone marrow disorder treatment approved by the FDA after nearly a decade
Celgene’s Inrebic becomes the first treatment for myelofibrosis to be approved by the US FDA since 2011 after having received a priority review and orphan drug designation.
Tiny bottles create controlled release system to deliver chemo
Nanoscale silica bottles, a five-hundredth of the diameter of a hair, could be used to deliver cancer drugs to specific disease sites in the body, avoiding debilitating side effects.